Cary J. Claiborne
Chief Executive Officer at Adial Pharmaceuticals Inc
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: Adial Pharmaceuticals Inc, 3 years.
Adial Pharmaceuticals Inc
Director · Chief Executive Officer
NeuroSense Therapeutics Ltd.
Director
Chief executive roles
Adial Pharmaceuticals Inc
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 7, 2026 | Adial Pharmaceuticals Inc | Grant or award | +37,985 | — | — |
| May 23, 2023 | Adial Pharmaceuticals Inc | Grant or award | +420,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.